{"id":327,"date":"2019-07-23T10:47:57","date_gmt":"2019-07-23T10:47:57","guid":{"rendered":"https:\/\/leap-agri.com\/?page_id=327"},"modified":"2019-07-31T15:09:15","modified_gmt":"2019-07-31T15:09:15","slug":"muvha","status":"publish","type":"page","link":"https:\/\/leap-agri.com\/?page_id=327","title":{"rendered":"MuVHA"},"content":{"rendered":"\n<blockquote class=\"wp-block-quote\"><p><strong><em>Multivalent inactivated Vaccine against Heartwater in Africa<\/em><\/strong><\/p><\/blockquote>\n\n\n\n<p><strong>Project consortium and fund<\/strong><\/p>\n\n\n\n<ul><li>CIRAD (France), coordinator, Philippe Holzmuller (PI): philippe.holzmuller@cirad.fr<\/li><li>CIRDES (Burkina Faso) (Abel Biguezoton: babels005@yahoo.fr) and INERA (Burkina Faso) (Adama Kabore: ade1_bf@yahoo.fr), sub-contracting EPAC (Benin) and NCoSL (Niger) for regional studies<\/li><li>ARC-OVI (South Africa) (Alri Pretorius: PretoriusAL@arc.agric.za) and University of Pretoria (South Africa) (Luis Neves: lneves17@gmail.com)<\/li><li>IBET (Portugal) (Paula Marques-Alves: marques@ibet.pt)<\/li><\/ul>\n\n\n\n<p><strong>Thematic and geographic area of the project: \u00a0\u00a0\u00a0 <\/strong><\/p>\n\n\n\n<ul><li>Sustainable food security <\/li><li>Animal sciences <\/li><li>Pest and disease control <\/li><li>Rural development and agricultural economy<\/li><\/ul>\n\n\n\n<p>The MuVHA project aims at providing an efficient multivalent inactivated vaccine against heartwater to improve animal health of ruminants, particularly small ruminants that are important for local economy in Africa. The development, acceptance and use of this new vaccine will not only participate in improving knowledge in Animal sciences and in targeting disease control, but will also bring new insights in sustainable food security as well as rural development and agricultural economy.<\/p>\n\n\n\n<p><strong>Project\u2019s summary\/abstract: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n\n\n\n<p>Heartwater, caused by <em>Ehrlichia ruminantium<\/em> (ER) constitute a\nmajor threat to ruminant production in Africa, affecting mainly small\nruminants. Although a commercial vaccine is available, it presents so many\ndrawbacks that its use is limited. An efficient, cost-effective and safe\nvaccine against heartwater to alleviate poverty of smallholder farmers and\ncontribute to a sustainable agriculture in Africa is needed. The inactivated\nvaccine constitutes the most advanced experimental vaccine against heartwater.\nThe main drawback of any experimental vaccine is the high antigenic diversity\nof ER strains, limiting its efficacy under field conditions. Our consortium\ncomposed of 2 European and 4 African partners propose to tackle this limitation\nby including a cocktail of strains of different regional genotypes newly\nisolated within the project. The genetic diversity of ER strains from Benin,\nBurkina Faso, Niger and South Africa, will be analyzed and ER strains will be\nisolated from West African and Southern Africa countries to allow the design of\nregional vaccines. The efficacy of the inactivated vaccines will be improved by\nincluding several ER strains selected depending on their genotypes. The vaccines\nwill be tested in field conditions in Burkina Faso and South Africa, with a new\npromising oil adjuvant and with a single injection, and protective biomarkers\nwill be identified to minimize the need for challenges after any new vaccine\ntrials. Process of production of improved vaccine formulations at industrial\nlevel will be available at the end of the project. The current project will\nalso allow increasing regional heartwater diagnostic and research capacities.\nSpecial efforts will be done to share the research products with stakeholders such\nas farmers and local manufacturers.<\/p>\n\n\n\n<p><strong>Project\u2019s main objective(s):\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/strong><\/p>\n\n\n\n<p>The main\nobjective of the MuVHA project is to prove the ability to define and to develop\nan efficient inactivated vaccine against HW, adapted to a specific geographical\nregion and based on a cocktail of ER strains, easy to produce by regional\nmanufacturers and easy to use by veterinary services and farmers. <\/p>\n\n\n\n<p>Scientific objectives are: <\/p>\n\n\n\n<ol><li>evaluate the efficacy of the inactivated regional cocktail vaccine in field trials both in Western and Southern Africa after characterization of ER genetic diversity and isolation of current main regional strains <\/li><li>identify and validate biomarkers associated to protection and\/or vaccination and <\/li><li>design a rapid test to differentiate vaccinated\/protected animals from na\u00efve animals. <\/li><\/ol>\n\n\n\n<p>The novelty relies on the definition of the multivalent inactivated vaccine targeting the regional ER strains together with the identification of vaccination efficiency markers and the promotion of regional manufacturing with regular updating of the vaccine. <\/p>\n\n\n\n<p><strong>Theory of Change and Impact Pathway<\/strong><\/p>\n\n\n\n<p><em>Summary ToC with assumptions\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em><\/p>\n\n\n\n<p>The main objective of the MuVHA project is to\nobtain a high-quality, heat-stable, affordable multivalent inactivated vaccine\nagainst heartwater (HW), transferable to partner countries for a facilitated\nmass use, taking into account the specific contexts of the targeted regions of\nAfrica. The project integrates research and development activities to set up\nand validate the multivalent vaccine, together with capacity building and\ncommunication activities to ensure both a sustainable local expertise on the\ncontrol of HW and the adoption of the vaccine by farmers for widespread use.\nCurrent barriers to the use of the vaccine against heartwater (cold chain,\ninfectious risk, &#8230;) are integrated into the theory of change of the project\nwith the definition of standardized methods of production and quality control, all\ntaking into account farmers&#8217; expectations.<\/p>\n\n\n\n<p><em>Expected outcomes and impact: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/em><\/p>\n\n\n\n<p>Please\nmention the most expected outcomes of the project (e.g., the changes in\nbehaviour, relationships, actions and activities of stakeholders as a result of\nthe sharing and uptake of research.) and the contribution to impact the project\naims at (change in economic, environmental or social conditions) <\/p>\n\n\n\n<p>The context-adapted expected outcomes of the MuVHA\nproject are:<\/p>\n\n\n\n<ul><li>Strengthened capacity of regional partners for <em>Ehrlichia ruminantium<\/em> (ER) diagnostic and research through the creation of an experts network shared between South and West Africa and Europe;<\/li><li>Transdisciplinary communication strategy and capacity building (scientists and students, farmers associations, regional vaccine manufacturers, policy makers, \u2026) to achieve both scientific and technical knowledge on the vaccine production and adoption of its use;<\/li><li>Definition of ER current genetic diversity in West and South Africa and isolation of up to date ER strains to be targeted by the vaccine;<\/li><li>Establishment of standardised protocol and conditions for production of the emulsified vaccine and an efficient quality control protocol, with scale-up consideration for further industrial production by regional manufacturers;<\/li><li>An efficient improved (geographically adapted) inactivated multivalent vaccine against HW;<\/li><li>Identification of biomarkers associated with protective immune responses for vaccine efficacy follow-up.<\/li><\/ul>\n\n\n\n<p>The project management has been built in such a\nway as to involve each partner both in achieving the scientific objectives and\nin communicating with the local actors to guarantee the acceptance of the\nresults. Particular efforts will be made to inform and integrate, from the\nbeginning of the project, farmer communities, veterinary services and regional\nmanufacturers in the discussion of needs, expected and obtained results and\noutputs of the project, to ensure the correct use of the validated vaccine and\nto be able to transfer its production at the end of the project. The African\npartners, who work in close collaboration both with farmers and regional\nvaccine manufacturers, will be in charge of not only the communication campaign\nbut also in the capacity building of current technical staff and the training\nof students who will then reinforce and perpetuate the local scientific teams. The\nproject will help to strengthen the partnership between Western, South African\nand European partners in order to build a research network on HW for sustained\nresearch and development projects.<\/p>\n\n\n\n<p>First research outputs of the project are the\ncharacterization of ER genetic diversity in Burkina Faso, Niger, Benin and\nSouth Africa and the increased capacity of partners for ER diagnostic and\nresearch. Both collaboration within the project between partners and\norganization of trainings for students and research staff will allow\nstrengthening the regional expertise on HW.<\/p>\n\n\n\n<p>Second, the development of an improved\ninactivated multivalent vaccine with standardised conditions for emulsion step\nand injection mode will allow the availability of the process for production at\nindustrial level and harmonised use in the field. The transfer to regional\nmanufacturers will be effective when the efficacy of the vaccine will be assessed\nin the field. The evaluation of the multivalent vaccine in the field will allow\nthe isolation of breakthrough strains and then the building of bank of ER\nregional strains for vaccine production purposes. Optimisation of the\ninactivated vaccine against HW will have a positive impact on well-being of\nsmall farmers, specially women and children, by increasing the productivity of\ntheir herds and participating in food safety. Even if the multivalent vaccines\nwill be tested only in Burkina Faso and South Africa during the project,\nstandardised procedures will make it transferable to other African countries\nwith a specific design of strains for these regions.<\/p>\n\n\n\n<p>A communication plan with direct involvement of\nfarmer associations (questionnaires about their expectations for vaccination,\nleaflets on the importance and impact of vaccination, and adapted communication\ntools on the proper use of vaccines) will be developed to strongly help to\nadapt the take home message. A workshop gathering members of livestock vaccine\nproducers such as LNERV (Senegal), LNE (Burkina Faso), LCV (Mali), LABOCEL\n(Niger), South African manufacturers, farmers associations and policy makers\nwill be carried out at the end of the project to present results on inactivated\nvaccines and promote advancements towards commercialization and its modality of\nuse for farmers. Farmer associations will be useful to promote result\ndissemination regionally. Furthermore, since some of the partners belong to\nacademic or public scientific institutions, dissemination of scientific results\nwill also target high-level international peer-reviewed journals, regional and\ninternational conferences. The policy of the consortium for publications will\nbe free access for the readers to spread the results widely.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Multivalent inactivated Vaccine against Heartwater in Africa Project consortium and fund CIRAD (France), coordinator, Philippe Holzmuller (PI): philippe.holzmuller@cirad.fr CIRDES (Burkina Faso) (Abel Biguezoton: babels005@yahoo.fr) and INERA (Burkina Faso) (Adama Kabore: ade1_bf@yahoo.fr), sub-contracting EPAC (Benin) and NCoSL (Niger) for regional studies ARC-OVI (South Africa) (Alri Pretorius: PretoriusAL@arc.agric.za) and University of Pretoria (South Africa) (Luis Neves: lneves17@gmail.com) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.14 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MuVHA - LEAP-Agri<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/leap-agri.com\/?page_id=327\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MuVHA - LEAP-Agri\" \/>\n<meta property=\"og:description\" content=\"Multivalent inactivated Vaccine against Heartwater in Africa Project consortium and fund CIRAD (France), coordinator, Philippe Holzmuller (PI): philippe.holzmuller@cirad.fr CIRDES (Burkina Faso) (Abel Biguezoton: babels005@yahoo.fr) and INERA (Burkina Faso) (Adama Kabore: ade1_bf@yahoo.fr), sub-contracting EPAC (Benin) and NCoSL (Niger) for regional studies ARC-OVI (South Africa) (Alri Pretorius: PretoriusAL@arc.agric.za) and University of Pretoria (South Africa) (Luis Neves: lneves17@gmail.com) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leap-agri.com\/?page_id=327\" \/>\n<meta property=\"og:site_name\" content=\"LEAP-Agri\" \/>\n<meta property=\"article:modified_time\" content=\"2019-07-31T15:09:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/leap-agri.com\/?page_id=327\",\"url\":\"https:\/\/leap-agri.com\/?page_id=327\",\"name\":\"MuVHA - LEAP-Agri\",\"isPartOf\":{\"@id\":\"https:\/\/leap-agri.com\/#website\"},\"datePublished\":\"2019-07-23T10:47:57+00:00\",\"dateModified\":\"2019-07-31T15:09:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/leap-agri.com\/?page_id=327#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/leap-agri.com\/?page_id=327\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/leap-agri.com\/?page_id=327#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/leap-agri.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MuVHA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/leap-agri.com\/#website\",\"url\":\"https:\/\/leap-agri.com\/\",\"name\":\"LEAP-Agri\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/leap-agri.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/leap-agri.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/leap-agri.com\/#organization\",\"name\":\"LEAP.Agri\",\"url\":\"https:\/\/leap-agri.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/leap-agri.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i2.wp.com\/leap-agri.com\/wp-content\/uploads\/2019\/07\/cropped-logo-bandiera-comm-EU.png?fit=800%2C322&ssl=1\",\"contentUrl\":\"https:\/\/i2.wp.com\/leap-agri.com\/wp-content\/uploads\/2019\/07\/cropped-logo-bandiera-comm-EU.png?fit=800%2C322&ssl=1\",\"width\":800,\"height\":322,\"caption\":\"LEAP.Agri\"},\"image\":{\"@id\":\"https:\/\/leap-agri.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MuVHA - LEAP-Agri","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/leap-agri.com\/?page_id=327","og_locale":"en_US","og_type":"article","og_title":"MuVHA - LEAP-Agri","og_description":"Multivalent inactivated Vaccine against Heartwater in Africa Project consortium and fund CIRAD (France), coordinator, Philippe Holzmuller (PI): philippe.holzmuller@cirad.fr CIRDES (Burkina Faso) (Abel Biguezoton: babels005@yahoo.fr) and INERA (Burkina Faso) (Adama Kabore: ade1_bf@yahoo.fr), sub-contracting EPAC (Benin) and NCoSL (Niger) for regional studies ARC-OVI (South Africa) (Alri Pretorius: PretoriusAL@arc.agric.za) and University of Pretoria (South Africa) (Luis Neves: lneves17@gmail.com) [&hellip;]","og_url":"https:\/\/leap-agri.com\/?page_id=327","og_site_name":"LEAP-Agri","article_modified_time":"2019-07-31T15:09:15+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/leap-agri.com\/?page_id=327","url":"https:\/\/leap-agri.com\/?page_id=327","name":"MuVHA - LEAP-Agri","isPartOf":{"@id":"https:\/\/leap-agri.com\/#website"},"datePublished":"2019-07-23T10:47:57+00:00","dateModified":"2019-07-31T15:09:15+00:00","breadcrumb":{"@id":"https:\/\/leap-agri.com\/?page_id=327#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leap-agri.com\/?page_id=327"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/leap-agri.com\/?page_id=327#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/leap-agri.com\/"},{"@type":"ListItem","position":2,"name":"MuVHA"}]},{"@type":"WebSite","@id":"https:\/\/leap-agri.com\/#website","url":"https:\/\/leap-agri.com\/","name":"LEAP-Agri","description":"","publisher":{"@id":"https:\/\/leap-agri.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leap-agri.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leap-agri.com\/#organization","name":"LEAP.Agri","url":"https:\/\/leap-agri.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leap-agri.com\/#\/schema\/logo\/image\/","url":"https:\/\/i2.wp.com\/leap-agri.com\/wp-content\/uploads\/2019\/07\/cropped-logo-bandiera-comm-EU.png?fit=800%2C322&ssl=1","contentUrl":"https:\/\/i2.wp.com\/leap-agri.com\/wp-content\/uploads\/2019\/07\/cropped-logo-bandiera-comm-EU.png?fit=800%2C322&ssl=1","width":800,"height":322,"caption":"LEAP.Agri"},"image":{"@id":"https:\/\/leap-agri.com\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/leap-agri.com\/index.php?rest_route=\/wp\/v2\/pages\/327"}],"collection":[{"href":"https:\/\/leap-agri.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/leap-agri.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/leap-agri.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/leap-agri.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=327"}],"version-history":[{"count":2,"href":"https:\/\/leap-agri.com\/index.php?rest_route=\/wp\/v2\/pages\/327\/revisions"}],"predecessor-version":[{"id":404,"href":"https:\/\/leap-agri.com\/index.php?rest_route=\/wp\/v2\/pages\/327\/revisions\/404"}],"wp:attachment":[{"href":"https:\/\/leap-agri.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}